Landiolol hydrochloride for prevention of postoperative atrial fibrillation after esophageal cancer surgery: The double-blind, randomized, placebo-controlled trial
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2017
Price : $35 *
At a glance
- Drugs Landiolol (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms APPLE
- 01 Jul 2017 Primary endpoint (Incidence of atrial fibrillation ) has been met, as per the results published in the British Journal of Surgery.
- 01 Jul 2017 Results published in the British Journal of Surgery
- 01 Jul 2017 Status changed from active, no longer recruiting to completed, as per results published in the British Journal of Surgery.